CN201965131U - Quick test paper of hepatitis A virus (HAV) IgM antibody - Google Patents
Quick test paper of hepatitis A virus (HAV) IgM antibody Download PDFInfo
- Publication number
- CN201965131U CN201965131U CN2010206658394U CN201020665839U CN201965131U CN 201965131 U CN201965131 U CN 201965131U CN 2010206658394 U CN2010206658394 U CN 2010206658394U CN 201020665839 U CN201020665839 U CN 201020665839U CN 201965131 U CN201965131 U CN 201965131U
- Authority
- CN
- China
- Prior art keywords
- line
- pad
- hav
- sample
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000012360 testing method Methods 0.000 title claims abstract description 40
- 241000709721 Hepatovirus A Species 0.000 title abstract description 23
- 239000000427 antigen Substances 0.000 claims abstract description 24
- 102000036639 antigens Human genes 0.000 claims abstract description 24
- 108091007433 antigens Proteins 0.000 claims abstract description 24
- 239000000020 Nitrocellulose Substances 0.000 claims abstract description 16
- 229920001220 nitrocellulos Polymers 0.000 claims abstract description 16
- 239000012528 membrane Substances 0.000 claims abstract description 9
- 238000001514 detection method Methods 0.000 claims description 30
- 241000700605 Viruses Species 0.000 claims description 12
- 239000003365 glass fiber Substances 0.000 claims description 6
- 239000004745 nonwoven fabric Substances 0.000 claims description 6
- 241001494479 Pecora Species 0.000 claims description 4
- 239000002250 absorbent Substances 0.000 claims description 2
- 230000002745 absorbent Effects 0.000 claims description 2
- 238000012856 packing Methods 0.000 claims description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 abstract description 16
- 230000035945 sensitivity Effects 0.000 abstract description 4
- 238000003908 quality control method Methods 0.000 abstract description 3
- 238000006243 chemical reaction Methods 0.000 abstract description 2
- 238000010790 dilution Methods 0.000 abstract description 2
- 239000012895 dilution Substances 0.000 abstract description 2
- 239000007788 liquid Substances 0.000 abstract description 2
- 241000283707 Capra Species 0.000 abstract 1
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 230000008105 immune reaction Effects 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 14
- 239000003153 chemical reaction reagent Substances 0.000 description 12
- 238000001035 drying Methods 0.000 description 10
- FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 description 9
- 238000000034 method Methods 0.000 description 7
- 239000012530 fluid Substances 0.000 description 5
- 239000010931 gold Substances 0.000 description 5
- 229910052737 gold Inorganic materials 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 230000001154 acute effect Effects 0.000 description 4
- 239000000084 colloidal system Substances 0.000 description 4
- 208000005252 hepatitis A Diseases 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 229960003511 macrogol Drugs 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 206010019799 Hepatitis viral Diseases 0.000 description 2
- NMWONDKHBZEDMY-UHFFFAOYSA-H [Au](Cl)(Cl)Cl.C(CC(O)(C(=O)[O-])CC(=O)[O-])(=O)[O-].[Na+].[Na+].[Na+] Chemical compound [Au](Cl)(Cl)Cl.C(CC(O)(C(=O)[O-])CC(=O)[O-])(=O)[O-].[Na+].[Na+].[Na+] NMWONDKHBZEDMY-UHFFFAOYSA-H 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 238000013399 early diagnosis Methods 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 201000001862 viral hepatitis Diseases 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000012631 diagnostic technique Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000002360 explosive Substances 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- FDWREHZXQUYJFJ-UHFFFAOYSA-M gold monochloride Chemical compound [Cl-].[Au+] FDWREHZXQUYJFJ-UHFFFAOYSA-M 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000003317 immunochromatography Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 238000003760 magnetic stirring Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- 229940038773 trisodium citrate Drugs 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
Images
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010206658394U CN201965131U (en) | 2010-12-17 | 2010-12-17 | Quick test paper of hepatitis A virus (HAV) IgM antibody |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010206658394U CN201965131U (en) | 2010-12-17 | 2010-12-17 | Quick test paper of hepatitis A virus (HAV) IgM antibody |
Publications (1)
Publication Number | Publication Date |
---|---|
CN201965131U true CN201965131U (en) | 2011-09-07 |
Family
ID=44527677
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010206658394U Expired - Lifetime CN201965131U (en) | 2010-12-17 | 2010-12-17 | Quick test paper of hepatitis A virus (HAV) IgM antibody |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN201965131U (en) |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102608313A (en) * | 2012-02-27 | 2012-07-25 | 中国疾病预防控制中心病毒病预防控制所 | Anti-hepatitis A virus IgM (immunoglobulin M) AlphaLISA detection kit |
CN102680694A (en) * | 2012-05-24 | 2012-09-19 | 蓝十字生物药业(北京)有限公司 | Colloidal gold test strip for rapid detection of Human enterovirus 71 (EV71) IgM (immunoglobulin m) |
CN102692502A (en) * | 2012-04-26 | 2012-09-26 | 北京北方生物技术研究所 | Rapid hepatitis A virus IgM antibody detection kit and preparation method thereof |
CN103336119A (en) * | 2013-06-27 | 2013-10-02 | 潍坊市康华生物技术有限公司 | Anti-HAV (hepatitis A virus) colloidal gold test kit |
CN103364561A (en) * | 2013-07-29 | 2013-10-23 | 武汉中博生物股份有限公司 | Porcine circovirus 2 (PCV2) antibody colloidal gold immunity chromatography detection test paper and making method thereof |
CN103399154A (en) * | 2013-07-29 | 2013-11-20 | 武汉中博生物股份有限公司 | Test paper for colloidal gold immunochromatograohic assay of IgG (immunoglobulin G) antibody of dog anti-rabies virus and preparation method of test paper |
CN103969440A (en) * | 2014-05-27 | 2014-08-06 | 武汉中博生物股份有限公司 | Porcine reproductive and respiratory syndrome virus (PRRSV) IgM antibody colloidal gold immunochromatographic assay test paper, and preparation method and application thereof |
CN103969451A (en) * | 2014-05-27 | 2014-08-06 | 武汉中博生物股份有限公司 | Porcine circovirus type 2 (PCV2) IgM antibody colloidal gold immunochromatographic assay test paper, and preparation method and application thereof |
CN103983781A (en) * | 2014-05-27 | 2014-08-13 | 武汉中博生物股份有限公司 | Porcine pseudorabies virus gE IgM antibody colloidal gold immunochromatograohic assay test strip as well as preparation method and application thereof |
CN104330569A (en) * | 2014-10-29 | 2015-02-04 | 武汉生命科技股份有限公司 | Test strip for quickly detecting antibody |
CN104515850A (en) * | 2013-09-30 | 2015-04-15 | 万冰 | Quick test device and quick test method |
CN116087534A (en) * | 2022-12-30 | 2023-05-09 | 天津德祥生物技术股份有限公司 | Erythrocyte antigen detection method and detection kit |
CN116087534B (en) * | 2022-12-30 | 2024-05-10 | 天津德祥生物技术股份有限公司 | Erythrocyte antigen detection method and detection kit |
-
2010
- 2010-12-17 CN CN2010206658394U patent/CN201965131U/en not_active Expired - Lifetime
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102608313A (en) * | 2012-02-27 | 2012-07-25 | 中国疾病预防控制中心病毒病预防控制所 | Anti-hepatitis A virus IgM (immunoglobulin M) AlphaLISA detection kit |
CN102692502B (en) * | 2012-04-26 | 2015-02-04 | 北京北方生物技术研究所 | Rapid hepatitis A virus IgM antibody detection kit and preparation method thereof |
CN102692502A (en) * | 2012-04-26 | 2012-09-26 | 北京北方生物技术研究所 | Rapid hepatitis A virus IgM antibody detection kit and preparation method thereof |
CN102680694A (en) * | 2012-05-24 | 2012-09-19 | 蓝十字生物药业(北京)有限公司 | Colloidal gold test strip for rapid detection of Human enterovirus 71 (EV71) IgM (immunoglobulin m) |
CN103336119A (en) * | 2013-06-27 | 2013-10-02 | 潍坊市康华生物技术有限公司 | Anti-HAV (hepatitis A virus) colloidal gold test kit |
CN103336119B (en) * | 2013-06-27 | 2015-07-29 | 潍坊市康华生物技术有限公司 | Anti-HAV collaurum detects box |
CN103399154B (en) * | 2013-07-29 | 2015-07-15 | 武汉中博生物股份有限公司 | Test paper for colloidal gold immunochromatograohic assay of IgG (immunoglobulin G) antibody of dog anti-rabies virus and preparation method of test paper |
CN103399154A (en) * | 2013-07-29 | 2013-11-20 | 武汉中博生物股份有限公司 | Test paper for colloidal gold immunochromatograohic assay of IgG (immunoglobulin G) antibody of dog anti-rabies virus and preparation method of test paper |
CN103364561A (en) * | 2013-07-29 | 2013-10-23 | 武汉中博生物股份有限公司 | Porcine circovirus 2 (PCV2) antibody colloidal gold immunity chromatography detection test paper and making method thereof |
CN104515850A (en) * | 2013-09-30 | 2015-04-15 | 万冰 | Quick test device and quick test method |
CN104515850B (en) * | 2013-09-30 | 2019-05-03 | 万冰 | Device for quick testing and method |
CN103969451A (en) * | 2014-05-27 | 2014-08-06 | 武汉中博生物股份有限公司 | Porcine circovirus type 2 (PCV2) IgM antibody colloidal gold immunochromatographic assay test paper, and preparation method and application thereof |
CN103983781A (en) * | 2014-05-27 | 2014-08-13 | 武汉中博生物股份有限公司 | Porcine pseudorabies virus gE IgM antibody colloidal gold immunochromatograohic assay test strip as well as preparation method and application thereof |
CN103969440A (en) * | 2014-05-27 | 2014-08-06 | 武汉中博生物股份有限公司 | Porcine reproductive and respiratory syndrome virus (PRRSV) IgM antibody colloidal gold immunochromatographic assay test paper, and preparation method and application thereof |
CN104330569A (en) * | 2014-10-29 | 2015-02-04 | 武汉生命科技股份有限公司 | Test strip for quickly detecting antibody |
CN116087534A (en) * | 2022-12-30 | 2023-05-09 | 天津德祥生物技术股份有限公司 | Erythrocyte antigen detection method and detection kit |
CN116087534B (en) * | 2022-12-30 | 2024-05-10 | 天津德祥生物技术股份有限公司 | Erythrocyte antigen detection method and detection kit |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN201965131U (en) | Quick test paper of hepatitis A virus (HAV) IgM antibody | |
CN104502586B (en) | A kind of immunochromatography detection method and test paper | |
CN105092861A (en) | Immunofluorescence chromatography test paper for CRP (C-reaction protein)/SAA (Serum amyloid A protein) quantitative combined detection and preparation method of immunofluorescence chromatography test paper | |
CN104330553B (en) | A kind of unmarked chemiluminescence immunoassay sensor and immune analysis method thereof | |
EP1933140B1 (en) | Antibody detection method involving an oligonucleotide enhanced collodial gold signal | |
KR20120017884A (en) | Development of lateral flow assay using protein g coated magnetic bead and immunochromomatograpic strip and immunochromomatograpic kit | |
WO2015080286A1 (en) | Immunochromatography-assisted detection method | |
CN101266248A (en) | HCV IgM antibody rapid detection test paper | |
CN105785041A (en) | Test strip for quantitatively detecting calprotectin, preparation method thereof and determining method for calprotectin concentration | |
CN201522494U (en) | Duplex occult blood fast diagnositic and chromatographic test paper | |
US20210247395A1 (en) | Antibody pairs for use in a rapid influenza b diagnostic test | |
CN201413329Y (en) | AI9A antibody combined quick detecting test paper of Epstein-Barr virus capsid antigen VCA and thymidine kinase TK albumen immuneoglobrin | |
KR101587645B1 (en) | Multi-influenza Detection Kit and Method for Detecting Influenza Using the Same | |
KR20160120675A (en) | Rapid Quantitative Diagnostic Kit | |
WO2005062052A1 (en) | Simple membrane assay method and kit | |
CN101762692A (en) | Magnetic immunochromatographic strip for detection of tuberculosis (TB) antibody in blood and preparation method thereof | |
CN101788562A (en) | Influenza A (H1N1) virus total antibody rapid detection test paper | |
US20230026892A1 (en) | Lateral flow assay for detecting multiple proteins of a pathogen | |
CN204188618U (en) | A kind of DDi immunochromatography half-quantitative detection test paper | |
WO2019241184A1 (en) | Antibody pairs for use in a rapid influenza a diagnostic test | |
CN103424548A (en) | Tubercle mycobacteria antibody quickly detecting card and detecting method thereof | |
CN101614740B (en) | Hepatitis A virus antigen saliva fast detection test paper strip | |
CN103163298B (en) | Rapid detective reagent strip of treponema pallidum immunoglobulin m (IgM) antibody and preparation method thereof | |
CN205027759U (en) | Note is inspected soon to trigeminy antibody | |
US20100047799A1 (en) | Urinary immunochromatographic multiparameter detection cup |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of utility model: Quick test paper of hepatitis A virus (HAV) IgM antibody Effective date of registration: 20121210 Granted publication date: 20110907 Pledgee: Tianjin TEDA Small Enterprise Credit Guarantee Center Pledgor: Newscen Coast Bio-Pharmaceutical Co., Ltd. Registration number: 2012990000773 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of utility model: Quick test paper of hepatitis A virus (HAV) IgM antibody Effective date of registration: 20140212 Granted publication date: 20110907 Pledgee: Tianjin TEDA Small Enterprise Credit Guarantee Center Pledgor: Newscen Coast Bio-Pharmaceutical Co., Ltd. Registration number: 2014120000005 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20131224 Granted publication date: 20110907 Pledgee: Tianjin TEDA Small Enterprise Credit Guarantee Center Pledgor: Newscen Coast Bio-Pharmaceutical Co., Ltd. Registration number: 2012990000773 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20141231 Granted publication date: 20110907 Pledgee: Tianjin TEDA Small Enterprise Credit Guarantee Center Pledgor: Newscen Coast Bio-Pharmaceutical Co., Ltd. Registration number: 2014120000005 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of utility model: Quick test paper of hepatitis A virus (HAV) IgM antibody Effective date of registration: 20150204 Granted publication date: 20110907 Pledgee: Tianjin TEDA Small Enterprise Credit Guarantee Center Pledgor: Newscen Coast Bio-Pharmaceutical Co., Ltd. Registration number: 2015120000009 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20160307 Granted publication date: 20110907 Pledgee: Tianjin TEDA Small Enterprise Credit Guarantee Center Pledgor: Newscen Coast Bio-Pharmaceutical Co., Ltd. Registration number: 2015120000009 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
CP03 | Change of name, title or address |
Address after: 300457 Binhai New Area, Tianjin economic and Technological Development Zone, No. sixth main street, No. 65 Patentee after: Tianjin new torch bio pharmaceutical Limited by Share Ltd Address before: 300384 Tanggu Development Zone, Tianjin, No. Sixth Street, No. 65 Patentee before: Newscen Coast Bio-Pharmaceutical Co., Ltd. |
|
CP03 | Change of name, title or address | ||
CX01 | Expiry of patent term | ||
CX01 | Expiry of patent term |
Granted publication date: 20110907 |